About Algorithmic Biologics

Algorithmic Biologics develops a software platform that enhances molecular testing workflows through advanced computational applications, including compression algorithms for next-generation sequencing. This technology significantly reduces library preparation costs by over 60%, making molecular diagnostics more accessible and efficient for healthcare providers.

<problem> Traditional molecular testing workflows can be expensive and time-consuming, particularly in library preparation for next-generation sequencing (NGS), which limits accessibility and efficiency for healthcare providers. High costs and complex procedures create barriers to widespread adoption of molecular diagnostics and discovery. </problem> <solution> Algorithmic Biologics offers a software platform that enhances molecular testing by applying advanced computational methods, including compression algorithms for NGS. Their technology reduces library preparation costs by over 60% while maintaining high concordance. The platform integrates with existing molecular testing workflows, enabling computing applications that improve the accuracy, affordability, and accessibility of molecular diagnostics. By using AI and decades of research in molecular computing and reaction networks, Algorithmic Biologics aims to democratize access to NGS and other molecular tests. </solution> <features> - Compression algorithms for NGS that reduce library preparation costs by >60% - AI-powered platform that wraps around standard molecular testing workflows - Technology agnostic to the underlying molecular test, integrating with existing infrastructure - Single round, quantitative pooling algorithm with RT-qPCR for affordable and frequent testing - High concordance in validation studies performed with leading genomics research labs - DCGI approved and CE mark for IVD </features> <target_audience> The primary customers are healthcare providers, genomics research labs, and clinical partners seeking to enhance molecular testing workflows, reduce costs, and improve the accessibility of molecular diagnostics. </target_audience>

What does Algorithmic Biologics do?

Where is Algorithmic Biologics located?

Algorithmic Biologics is based in Alo, India.

When was Algorithmic Biologics founded?

Algorithmic Biologics was founded in 2021.

How much funding has Algorithmic Biologics raised?

Algorithmic Biologics has raised 2830000.

Location

Alo, India

Founded

2021

Funding

2830000

Employees

11 employees

Major Investors

Bharat Innovation Fund

Find Investable Startups and Competitors

Search thousands of startups using natural language

AI voice (2021+)underground pipe robots energy flexibility software

Start Searching

Algorithmic Biologics

⚠️ AI-generated overview based on web search data – may contain errors, please verify information yourself! You can claim this account with your email domain to make edits.

Executive Summary

algorithmicbiologics.com 1K+

Crunchbase

Founded 2021 – Alo, India

Funding

Estimated Funding

$2M+

Major Investors

Bharat Innovation Fund

Team (10+)

No team information available.

Company Description

Problem

Traditional molecular testing workflows can be expensive and time-consuming, particularly in library preparation for next-generation sequencing (NGS), which limits accessibility and efficiency for healthcare providers. High costs and complex procedures create barriers to widespread adoption of molecular diagnostics and discovery.

Solution

Algorithmic Biologics offers a software platform that enhances molecular testing by applying advanced computational methods, including compression algorithms for NGS. Their technology reduces library preparation costs by over 60% while maintaining high concordance. The platform integrates with existing molecular testing workflows, enabling computing applications that improve the accuracy, affordability, and accessibility of molecular diagnostics. By using AI and decades of research in molecular computing and reaction networks, Algorithmic Biologics aims to democratize access to NGS and other molecular tests.

Features

Compression algorithms for NGS that reduce library preparation costs by >60%

AI-powered platform that wraps around standard molecular testing workflows

Technology agnostic to the underlying molecular test, integrating with existing infrastructure

Single round, quantitative pooling algorithm with RT-qPCR for affordable and frequent testing

High concordance in validation studies performed with leading genomics research labs

DCGI approved and CE mark for IVD

Target Audience

The primary customers are healthcare providers, genomics research labs, and clinical partners seeking to enhance molecular testing workflows, reduce costs, and improve the accessibility of molecular diagnostics.